Latest Executive Appointment News

Forrestania Resources Limited has made significant strides in its expansion strategy during Q2 2025/2026, marked by the acquisition of Kula Gold Ltd, a substantial capital raise, and multiple project acquisitions across Western Australia.

Podium Minerals has made significant strides at its Parks Reef PGM Project, launching a game-changing concentrator flowsheet and progressing a multi-phase drilling campaign, all supported by a successful A$12 million capital raise amid soaring platinum group metal prices.

Bapcor Limited has revised its first-half FY26 guidance to a statutory net loss, citing weaker trade segment performance and one-off costs, while maintaining a cautiously optimistic full-year outlook supported by cost savings and leadership changes.

Melbana Energy has confirmed that its Executive Chairman, Andrew Purcell, is exempt from re-election under ASX Listing Rule 14.4, following a detailed response to ASX's compliance query.

Deep Yellow Limited has appointed Greg Field as its new Managing Director and CEO, aiming to leverage his extensive project execution experience to advance key uranium projects in Namibia and Australia.

Minerals 260 Limited has doubled the Mineral Resource Estimate for its Bullabulling Gold Project to 4.5 million ounces, positioning it among Australia’s top gold assets. The update follows extensive 2025 drilling and sets the stage for a Pre-Feasibility Study targeting production by late 2028.

Synertec Corporation reported resilience in FY25 despite sector headwinds, with a strong rebound in engineering profits and a 90% revenue jump in its renewable Powerhouse technology.

Gateway Mining has completed its acquisition of the Yandal Gold Project, revealing promising high-grade gold results and securing $22.5 million to fuel extensive exploration and drilling programs.

Thunderbird Resources has executed a binding agreement to acquire 100% of the Springfield Gold Deposit in NSW, an advanced project with significant high-grade gold mineralisation. The company also raised $2.2 million to fund exploration and appointed new senior executives to drive growth.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Astral Resources reports robust exploration results across its Western Australian gold projects and key progress on the Mandilla Definitive Feasibility Study, alongside a new joint venture at the Think Big deposit.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.